Literature DB >> 8947461

Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus.

J C Irminger1, K Meyer, P Halban.   

Abstract

Proinsulin is converted to insulin by the two endoproteases PC2 and PC3. For complete conversion to insulin, cleavage must occur at both the B-chain/C-peptide and C-peptide/A-chain junctions of proinsulin. Studies in vitro have shown the specificity of PC3 for the B-chain/C-peptide junction and that of PC2 for the C-peptide/A-chain junction. In contrast, studies in vivo have suggested that the proinsulin cleavage substrate specificity of these two endoproteases might be more complex. We have now used recombinant adenovirus to overexpress PC2 or PC3 in the rat insulinoma cell line INS. These cells convert proinsulin more slowly than primary pancreatic beta-cells, possibly reflecting their lower levels of PC3. Infection of INS cells with the corresponding recombinant adenovirus led to 5-10-fold and 20-40-fold increases in PC2 and PC3 expression respectively. Recombinant adenovirus is thus an effective tool for expressing proteins at high levels in slow-growing INS cells. Overexpression of either PC2 or PC3 in INS cells led to a striking acceleration of conversion of proinsulin to insulin and to a decreased accumulation of the conversion intermediate des-64.65-split proinsulin (cleaved only at the A-chain/C-peptide junction). There was no detectable accumulation of des-31.32-split proinsulin (cleaved only at the B-chain /C-peptide junction) after overexpression of either enzyme. Taken together, the data indicate that when expressed at high levels, both PC2 and PC3 seem to be able to cleave proinsulin at both its junctions in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8947461      PMCID: PMC1217891          DOI: 10.1042/bj3200011

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases.

Authors:  H W Davidson; C J Rhodes; J C Hutton
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

2.  A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5.

Authors:  W J McGrory; D S Bautista; F L Graham
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

3.  Proinsulin endopeptidase substrate specificities defined by site-directed mutagenesis of proinsulin.

Authors:  K Docherty; C J Rhodes; N A Taylor; K I Shennan; J C Hutton
Journal:  J Biol Chem       Date:  1989-11-05       Impact factor: 5.157

4.  Identification of the type 2 proinsulin processing endopeptidase as PC2, a member of the eukaryote subtilisin family.

Authors:  D L Bennett; E M Bailyes; E Nielsen; P C Guest; N G Rutherford; S D Arden; J C Hutton
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

5.  Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.

Authors:  D E Peavy; M R Brunner; W C Duckworth; C S Hooker; B H Frank
Journal:  J Biol Chem       Date:  1985-11-15       Impact factor: 5.157

6.  Differential processing of proglucagon by the subtilisin-like prohormone convertases PC2 and PC3 to generate either glucagon or glucagon-like peptide.

Authors:  Y Rouillé; S Martin; D F Steiner
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

7.  Isolation of two complementary deoxyribonucleic acid clones from a rat insulinoma cell line based on similarities to Kex2 and furin sequences and the specific localization of each transcript to endocrine and neuroendocrine tissues in rats.

Authors:  D J Hakes; N P Birch; A Mezey; J E Dixon
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

8.  Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA.

Authors:  B T Bloomquist; B A Eipper; R E Mains
Journal:  Mol Endocrinol       Date:  1991-12

9.  Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines.

Authors:  M Asfari; D Janjic; P Meda; G Li; P A Halban; C B Wollheim
Journal:  Endocrinology       Date:  1992-01       Impact factor: 4.736

10.  Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.

Authors:  S V Sizonenko; P A Halban
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

View more
  9 in total

1.  Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).

Authors:  Rhonda D Wideman; Irene L Y Yu; Travis D Webber; C Bruce Verchere; James D Johnson; Anthony T Cheung; Timothy J Kieffer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 2.  Prohormone and proneuropeptide processing. Recent progress and future challenges.

Authors:  M C Beinfeld
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

3.  Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

Authors:  M Furuta; H Yano; A Zhou; Y Rouillé; J J Holst; R Carroll; M Ravazzola; L Orci; H Furuta; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

4.  Insulin resistance in HIV protease inhibitor-associated diabetes.

Authors:  K E Yarasheski; P Tebas; C Sigmund; S Dagogo-Jack; A Bohrer; J Turk; P A Halban; P E Cryer; W G Powderly
Journal:  J Acquir Immune Defic Syndr       Date:  1999-07-01       Impact factor: 3.731

5.  Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells.

Authors:  H Wang; M Iezzi; S Theander; P A Antinozzi; B R Gauthier; P A Halban; C B Wollheim
Journal:  Diabetologia       Date:  2005-03-09       Impact factor: 10.122

6.  Proinsulin maturation, misfolding, and proteotoxicity.

Authors:  Ming Liu; Israel Hodish; Christopher J Rhodes; Peter Arvan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-26       Impact factor: 11.205

7.  Defective transport of the obesity mutant PC1/3 N222D contributes to loss of function.

Authors:  Yogikala Prabhu; Elias H Blanco; Ming Liu; Juan R Peinado; Matthew C Wheeler; Nicholas Gekakis; Peter Arvan; Iris Lindberg
Journal:  Endocrinology       Date:  2014-05-14       Impact factor: 4.736

8.  A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell lines.

Authors:  Nan Sook Lee; Joyce G Rohan; Madison Zitting; Sonia Kamath; Andrew Weitz; Arnold Sipos; Paul M Salvaterra; Kouichi Hasegawa; Martin Pera; Robert H Chow
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

9.  Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases.

Authors:  D B Constam; E J Robertson
Journal:  J Cell Biol       Date:  1999-01-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.